After 30 Years, Here's Biden's Plan To Lower Drug Costs: Negotiate

Sydney Lupkin, NPR's pharmaceuticals correspondent, breaks down a pivotal moment in U.S. healthcare policy. The government can now negotiate Medicare drug prices, a move decades in the making. She discusses the ten drugs under negotiation and what that means for seniors facing high costs. The challenges ahead include pharmaceutical lobbying and potential legal battles. Furthermore, Lupkin analyzes how this initiative could sway upcoming elections and reshape public opinion on healthcare affordability. It's an enlightening conversation on a crucial topic.